D-1378-2016 Class II Terminated
FDA drug recall D-1378-2016 was initiated by Pharmedium Services, LLC on May 5, 2016 and is designated Class II. Reason for recall: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs. The recall status is terminated (terminated Mar 6, 2018). Affected quantity: 65 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 27, 2016
- Initiation Date
- May 5, 2016
- Termination Date
- Mar 6, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 65 bags
Product Description
10 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 ml in 250 ml Hospira LifeCare Bag ,Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-143-50
Reason for Recall
Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Distribution Pattern
Nationwide
Code Information
Service Code 2H8143 , Lot Number 160830115M , Exp. Date 6/22/2016 ; Service Code 2H8143 , Lot Number 160910155M , Exp. Date 6/30/2016 ; Service Code 2K8448 , Lot Number 160480205M , Exp. Date 5/12/2016 ; Service Code 2K8448 , Lot Number 160610064M , Exp. Date 5/24/2016 ; Service Code 2K8448 , Lot Number 160760042M , Exp. Date 6/9/2016 ; Service Code 2K8448 , Lot Number 160890047M , Exp. Date 6/22/2016 ;
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1378-2016
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026